SECOND REGULAR SESSION
SENATE BILL NO. 932
90TH GENERAL ASSEMBLY
INTRODUCED BY SENATOR SIMS.
Read 1st time January 27, 2000, and 1,000 copies ordered printed.
TERRY L. SPIELER, Secretary.
4266S.01I
AN ACT
To amend chapter 192, RSMo, by adding thereto one new section relating to obesity.
Section A. Chapter 192, RSMo, is amended by adding thereto one new section, to be known as section 192.955, to read as follows:
192.955. 1. As used in this section, the following terms mean:
(1) "Department", the department of health;
(2) "Obesity", a chronic disease characterized by the condition of having a body weight that is twenty percent or more over the ideal weight as determined by the life insurance statistics for a person's age, build, sex and height.
2. The department of health shall study and report to the governor, speaker of the house of representatives, and president pro tempore of the senate by December 31, 2000, the following:
(1) The incidence of obesity in Missouri, including information and statistics on any disparity within the population's demographics;
(2) The causal relationship in Missouri between obesity and other serious health complications, including, but not limited to hypertension, cardiovascular disease, stroke, diabetes, respiratory dysfunction, osteoarthritis, dyslipedemia, gall bladder disease and mortality; and
(3) Recommendations on reducing obesity in Missouri with an emphasis on children, women, minorities and other populations disproportionately affected by obesity.
3. The department may establish, promote and maintain obesity awareness prevention and education activities to promote public awareness of the causes of obesity, the value of early identification of risk factors, and options for prevention and treatment.
4. Pursuant to section 208.152, RSMo, individuals receiving medical assistance pursuant to section 208.151, RSMo, may receive outpatient prescription drug coverage of nonsystemic federal Food and Drug Administration-approved antiobesity drug therapies for eligible persons according to such drug's indications for usage as prescribed by the federal Food and Drug Administration.